The Swedish CArdioPulmonary bioImage Study, SCAPIS, is a nationwide, open-access, population-based cohort for the study of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).
30,154 men and women in Sweden, 50 to 64 years old, have been recruited and investigated with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The first public release of data is planned for March 2021. All researchers based in Sweden, or international researchers in collaboration with a researcher based in Sweden, will then be able to apply for data.
The novelty and significant contribution of SCAPIS is that it combines size with extensive phenotyping. The aim of SCAPIS is to predict and prevent CVD and CPD. The goal is to further develop individualized treatment and improve health care by building this research resource.
SCAPIS is a unique study made possible through a collaborative effort between six Swedish universities (Uppsala University, Umeå University, Linköping University, Lund University, University of Gothenburg and Karolinska Institutet) and university hospitals (Uppsala University Hospital, University Hospital of Umeå, Linköping University Hospital, Skåne University Hospital, Sahlgrenska University Hospital and Karolinska University Hospital).
SCAPIS main funder is the Swedish Heart-Lung Foundation and with considerable support from the Knut and Alice Wallenberg Foundation, Vinnova, The Swedish Research Council and the participating Universities and University Hospitals.